Sign In
Buy IRMD
$91.12
+1.26 (+1.40%)
At Close: Jun 03, 2026
Momentum Mondays: Stocks Setting up for an Epic Dip Buying Opportunity?
12:02pm, Monday, 21'st Aug 2023
Want to start the week ahead of the pack? Check out ‘Momentum Mondays,' where I cover the leading breakout stocks in the market, summarize the major events of the week ahead, and prepare investors f
Time to Buy These Medical Stocks as Earnings Approach
08:39pm, Monday, 14'th Aug 2023
Quarterly results from large retailers will highlight this week's earnings lineup but there are a few healthcare companies that investors will want to pay attention to as well.
iRadimed (IRMD) Is a Great Choice for 'Trend' Investors, Here's Why
10:02am, Friday, 11'th Aug 2023
iRadimed (IRMD) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our s
IRADIMED CORPORATION to Hold 2023 Second Quarter Financial Results Conference Call on August 3rd
08:45am, Thursday, 27'th Jul 2023
WINTER SPRINGS, Fla., July 27, 2023 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2023 second quarter financial results before the market o
2 Medical Stocks to Consider Buying in June
09:52pm, Wednesday, 28'th Jun 2023
With solid top and bottom-line growth on the horizon for HealthEquity (HQY) and iRadimed (IRMD), they are starting to look like viable investments for 2023 and beyond.
iRadimed (IRMD) is on the Move, Here's Why the Trend Could be Sustainable
10:34am, Tuesday, 27'th Jun 2023
iRadimed (IRMD) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
Recent Price Trend in iRadimed (IRMD) is Your Friend, Here's Why
09:52am, Thursday, 08'th Jun 2023
iRadimed (IRMD) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
iRadimed (IRMD) Is a Great Choice for 'Trend' Investors, Here's Why
09:58am, Thursday, 18'th May 2023
iRadimed (IRMD) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
IRadimed Corporation (IRMD) Q1 2023 Earnings Call Transcript
02:25am, Monday, 08'th May 2023
IRadimed Corporation (NASDAQ:IRMD ) Q1 2023 Earnings Conference Call May 4, 2023 11:00 AM ET Company Participants Roger Susi - President and Chief Executive Officer Jack Glenn - Chief Financial Office
IRadimed (IRMD) Surpasses Q1 Earnings and Revenue Estimates
11:27am, Thursday, 04'th May 2023
IRadimed (IRMD) came out with quarterly earnings of $0.30 per share, beating the Zacks Consensus Estimate of $0.27 per share. This compares to earnings of $0.22 per share a year ago.
IRADIMED CORPORATION to Hold 2023 First Quarter Financial Results Conference Call on May 4th
08:30am, Thursday, 27'th Apr 2023
WINTER SPRINGS, Fla., April 27, 2023 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2023 first quarter financial results before the market o
4 Best Profitable Stocks to Buy Banking on Net Income Ratio
08:25am, Tuesday, 14'th Mar 2023
MercadoLibre (MELI), iRadimed (IRMD), Northeast Community Bancorp (NECB) and AAON (AAON) have been selected as the top picks with a high net income ratio.
IRADIMED CORPORATION To Present at the 35th Annual Roth Conference
08:45am, Monday, 06'th Mar 2023
WINTER SPRINGS, Fla., March 06, 2023 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD) today announced that Roger Susi, President and Chief Executive Officer of the Company,
IRadimed: Revise To Buy With Exceptional Incremental ROIC In Q4
10:45am, Friday, 10'th Feb 2023
IRadimed came in with a strong set of Q4 and full-year numbers. We noted tremendous momentum on IRMD's profitability front, with strong incremental ROIC on small reinvestment for growth.
IRadimed Q4: A Bottom-Line Beat, A Special Cash Dividend, Maintain Buy
05:32am, Wednesday, 08'th Feb 2023
Revenues rose 25.2% YOY to $14.9 million, due to a rapid acceleration of Patient Monitors and Disposables sales, and a significant contribution from a new product launch. IRMD announced a special cash
